Kala’s dry eye syndrome steroid likely to be FDA approved; mixed potential on uptake

To gain FDA approval, DES treatments must demonstrate statistically significant improvements in both signs and symptoms. Credit: liza54500/Shutterstock.



  • Kala Biopharmaceuticals